Near infrared photoimmunotherapy prevents lung cancer metastases in a murine model

Oncotarget

Volumn 6, Issue 23, 2015, Pages 19747-19758

  Sato, Kazuhide ^a   Nagaya, Tadanobu ^a   Nakamura, Yuko ^a   Harada, Toshiko ^a   Choyke, Peter L ^a   Kobayashi, Hisataka ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

HER2 receptor; Metastasis prevention; Near infrared photoimmunotherapy; Targeted metastasis treatment

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; GREEN FLUORESCENT PROTEIN; HER2 ANTIBODY; LUCIFERASE; PHOTOSENSITIZING AGENT; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; ANTIBODY CONJUGATE; ANTINEOPLASTIC AGENT; TRASTUZUMAB;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CANCER PREVENTION; CANCER STAGING; CELL KILLING; CLINICAL EFFECTIVENESS; CONJUGATION; CONTROLLED STUDY; CYTOPLASM; CYTOTOXICITY; ENZYME ACTIVITY; FEMALE; FLUORESCENCE ANALYSIS; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; MOUSE; NEAR INFRARED PHOTOIMMUNOTHERAPY; NONHUMAN; PROTEIN DETERMINATION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; TREATMENT RESPONSE; 3T3 CELL LINE; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL SURVIVAL; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; IMMUNOTHERAPY; INFRARED RADIATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG NEOPLASMS; METABOLISM; NUDE MOUSE; PHOTOTHERAPY; PROCEDURES; SECONDARY; TIME FACTOR;

ANIMALS; ANTINEOPLASTIC AGENTS; BALB 3T3 CELLS; CELL SURVIVAL; FEMALE; IMMUNOCONJUGATES; IMMUNOTHERAPY; INFRARED RAYS; INJECTIONS, INTRAVENOUS; LUNG NEOPLASMS; MICE; MICE, NUDE; NIH 3T3 CELLS; PHOTOSENSITIZING AGENTS; PHOTOTHERAPY; RECEPTOR, ERBB-2; TIME FACTORS; TRANSFECTION; TRASTUZUMAB;

EID: 84939217196     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.3850     Document Type: Article

References (28)

1. Weichselbaum RR, Hellman S. Oligometastases revisited. Nat Rev Clin Oncol. 2011; 8:378-82. doi:10.1038/nrclinonc.2011.44.
2. Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med. 2006; 12:895-904. doi:10.1038/nm1469.
3. Mew D, Wat C, Towers GHN, Levy JG. Photoimmunotherapy: treatment of animal tumors with tumor-specific monoclonal antibody-hematoporphyrin conjugates. J Immunol. 1983; 130:1473-7.
4. Oseroff AR, Ohuoha D, Hasan T, Bommer JC, Yarmush ML. Antibody-targeted photolysis: selective photodestruction of human T-cell leukemia cells using monoclonal antibody-chlorin e6 conjugates. Proc Natl Acad Sci U S A. 1986; 83:8744-8.
5. Mitsunaga M, Ogawa M, Kosaka N, Rosenblum LT, Choyke PL, Kobayashi H. Cancer cell - selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules. Nat Med. 2011; 17:1685-91. doi:10.1038/nm.2554.
6. Sato K, Watanabe R, Hanaoka H, Harada T, Nakajima T, Kim I, Paik CH, Choyke PL, Kobayashi H. Photoimmunotherapy: Comparative effectiveness of two monoclonal antibodies targeting the epidermal growth factor receptor. Mol Oncol. 2014; 8:620-32. doi:10.1016/j. molonc.2014.01.006.
7. Sato K, Choyke PL, Kobayashi H. Photoimmunotherapy of Gastric Cancer Peritoneal Carcinomatosis in a Mouse Model. PLoS One. 2014; 9:e113276. doi:10.1371/journal. pone.0113276.
8. Francia G, Cruz-Munoz W, Man S, Xu P, Kerbel RS. Mouse models of advanced spontaneous metastasis for experimental therapeutics. Nat Rev Cancer. 2011; 11:135-41. doi:10.1038/nrc3001.
9. Conway JRW, Carragher NO, Timpson P. Developments in preclinical cancer imaging: innovating the discovery of therapeutics. Nat Rev Cancer. 2014; 14:314-28. doi:10.1038/nrc3724.
10. De Jong M, Essers J, van Weerden WM. Imaging preclinical tumour models: improving translational power. Nat Rev Cancer. 2014; 14:481-93. doi:10.1038/nrc3751.
11. Contag PR, Olomu IN, Stevenson DK CC. Bioluminescent indicators in living mammals. Nat Med. 1998; 4:245-7.
12. Rehemtulla A, Stegman LD, Cardozo SJ, Gupta S, Hall DE, Contag CH, Ross BD. Rapid and Quantitative Assessment of Cancer Treatment Response Using In Vivo Bioluminescence Imaging 1 Days post sham treatment. Neoplasia. 2000; 2:491-5.
13. Sato K, Hanaoka H, Watanabe R, Nakajima T, Choyke PL, Kobayashi H. Near infrared photoimmunotherapy in the treatment of disseminated peritoneal ovarian cancer. Mol Cancer Ther. 2015; Jan 14:141-50. doi: 10.1158/1535-7163.MCT-14-0658. Epub 2014 Nov 21.
14. Hoffman RM. The multiple uses of fluorescent proteins to visualize cancer in vivo. Nat Rev Cancer. 2005; 5:796-806. doi:10.1038/nrc1717.
15. Yamamoto N, Tsuchiya H, Hoffman RM. Tumor imaging with multicolor fluorescent protein expression. Int J Clin Oncol. 2011; 16:84-91. doi:10.1007/s10147-011-0201-y.
16. Koyama Y, Hama Y, Urano Y, Nguyen DM, Choyke PL, Kobayashi H. Spectral fluorescence molecular imaging of lung metastases targeting HER2/neu. Clin cancer Res. 2007; 13:2936-45. doi:10.1158/1078-0432.CCR-06-2240.
17. Yang M, Hasegawa S, Jiang P, Wang X, Tan Y, Chishima T, Shimada H, Moossa AR, Hoffman RM. Widespread skeletal metastatic potential of human lung cancer revealed by green fluorescent protein expression. Cancer Res. 1998; 58:4217-21.
18. Kimura H, Hayashi K, Yamauchi K, Yamamoto N, Tsuchiya H, Tomita K, Kishimoto H, Bouvet M, Hoffman RM. Real-time imaging of single cancer-cell dynamics of lung metastasis. J Cell Biochem. 2010; 109:58-64. doi:10.1002/jcb.22379.
19. Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science. 2011; 331:1559-64. doi:10.1126/science.1203543.
20. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer. 2002; 2:563-72. doi:10.1038/nrc865.
21. Fidler IJ. hypothesis revisited. Nat Rev Cancer. 2003; 3:1-6.
22. Sethi N, Kang Y. Unravelling the complexity of metastasis - molecular understanding and targeted therapies. Nat Rev Cancer. 2011; 11:735-48. doi:10.1038/nrc3125.
23. Nguyen DX, Bos PD, Massagué J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer. 2009; 9:274-84. doi:10.1038/nrc2622.
24. Treasure T, Miloševic M, Fiorentino F, Macbeth F. Pulmonary metastasectomy: what is the practice and where is the evidence for effectiveness?. Thorax. 2014; 69:946-9. doi:10.1136/thoraxjnl-2013-204528.
25. Shirasu N, Yamada H, Shibaguchi H, Kuroki M, Kuroki M. Potent and specific antitumor effect of CEA-targeted photoimmunotherapy. Int J Cancer. 2014; 135:2697-710. doi:10.1002/ijc.28907.
26. Sato K, Nagaya T, Choyke PL, Kobayashi H. Near Infrared Photoimmunotherapy in the Treatment of Pleural Disseminated NSCLC: Preclinical Experience. Theranostics. 2015; 5: 698-709. doi: 10.7150/thno.11559.
27. Nakajima T, Sano K, Choyke PL, Kobayashi H. Improving the efficacy of Photoimmunotherapy (PIT) using a cocktail of antibody conjugates in a multiple antigen tumor model. Theranostics. 2013; 3:357-65. doi:10.7150/thno.5908.
28. Sato K, Watanabe T, Wang S, Kakeno M, Matsuzawa K, Matsui T, Yokoi K, Murase K, Sugiyama I, Ozawa M, Kaibuchi K. Numb controls E-cadherin endocytosis through p120 catenin with aPKC. Mol Biol Cell. 2011; 22:3103-19. doi:10.1091/mbc.E11-03-0274.